09-09-2017 Our new distributors; IWAI JAPAN and USA, BioChemMack JCS Russia

News


09-09-2017 Our new Distributiors; IWAI JAPAN and USA, BioChemMack JCS Russia..


07-27-2017 5 New Publications are added; 2 patents, 2 peer reviewed articles and 1 PhD thesis..


07-10-2017 five new products for Pembrolizumab(Keytruda®),Ipilimumab(Yervoy®) and Filgrastim.


02-20-2017 new publication “H. Akbulut, et al: The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC). 1553 P, Annals of Oncology, Volume 27, 2016.


02-20-2017 New kit for quantitative measurement of anti-bevacizumab antibodies with confirmation reagentdone by using SHIKARI® ELISA kits.


02-06-2017 Two new kits for quantitative measurement of rituximab and anti-rituximab antibodies with confirmation reagent.


01-30-2017 Three new kits for quantitative measurement of anti-drug antibodies for infliximab, infliximab biosimilar CT-P13 and adalimumab with confirmation reagent.


01-13-2017 Updated forty publications done by using SHIKARI® ELISA kits.


MATRIKS BIOTECHNOLOGY CO., LTD

Gazi Üniversitesi Gölbaşı Yerleşkesi Teknoplaza Binası,
(B Blok Zemin Kat BZ17),
06830,
Gölbaşı/ANKARA/TÜRKİYE

Contact Details

Telephone: +90 (312) 485 42 94
Email: info@matriksbiotek.com
Fax: +90 (312) 485 11 87